Pine Pharmaceuticals visits Masters in Ophthalmology

Representatives from Pine Pharmaceuticals recently attended the  Florida Society of Ophthalmology ‘Masters in Ophthalmology‘ conference June 10-11 at The Ritz Carlton in Orlando, Fl.   During the exhibition Pine Pharmaceuticals was given an opportunity to introduce our new combination drops, TROPIcamide-PHENylephrine, to members of the society.  The response was tremendous and numerous physicians placed orders for TROPIcamide-PHENylephrine that… Read more »

PINE Pharmaceuticals to make their debut at ASCRS•ASOA Symposium & Congress in New Orleans.

PINE Pharmaceuticals will be exhibiting at booth #1407 this weekend at the ASCRS•ASOA Symposium & Congress in New Orleans.  This will be the company’s first time participating and it will also feature the debut of PINE Pharmaceuticals’ newest product, TROPIcamide-PHENylephrine, to leading practitioners in Ophthalmology.   TROPIcamide-PHENylephrine is available without patient names or prescriptions and is… Read more »

PINE Pharmaceuticals to launch new combination drops at ASRS Business of Retina Meeting

PINE Pharmaceuticals will introduce their new combination drops, TROPIcamide-PHENylephrine, at the upcoming ASRS Business of Retina Meeting in Dallas, TX.  TROPIcamide-PHENylephrine is available without patient names or prescriptions and is a compounded solution of Phenylephrine HCl 2.5% – Tropicamide 1% in a 15 mL dropper bottle.     PINE Pharmaceuticals representatives will be exhibiting and available to… Read more »

PINE Pharmaceuticals heads to Las Vegas for AAO 2015!

PINE Pharmaceuticals will be heading to Las Vegas in November to participate in the year’s largest Ophthalmology and Retina conference, AAO 2015.  PINE will be exhibiting at both the American Academy of Ophthalmology (AAO) Retina Subspecialty Day on November 13th and also the American Academy of Ophthalmology (AAO) main show November 14th – 17th.   Please… Read more »